EXTON, Pa., Jan. 12, 2026 /PRNewswire/ — West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the company has reached a definitive agreement to sell all manufacturing and supply rights for SmartDose® 3.5mL On-Body Delivery System and associated facilities to AbbVie (NYSE: ABBV) for total consideration of $112.5 million at close, subject to working capital and other adjustments. The definitive agreement, which is subject to certain closing conditions, is expected to close in mid-2026.

[Editors Note:  West Pharma manufacturers the SmartDose® 3.5mL On-Body Delivery System at its facilities in Tempe, AZ.]

Continue reading→

TUCSON, Ariz., Jan. 13, 2026 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced the launch of the Cruxx to MedTech Podcast discussing series exploring the SynCardia Total Artificial Heart (STAH) and the next generation, fully implantable Emperor device through the lens of patients and management.Continue reading→

Want to support and collaborate with ASU’s next generation of biomedical engineers? Have a project or a lingering problem you’d like to solve? Get fresh, innovative perspectives from a team of undergraduate senior students who are dedicated to finding your solution and will work on your proposed project for two full semesters.
Continue reading→

January 9, 2026 (Tucson, Ariz.) – One of Arizona’s most anticipated entrepreneurial events, IdeaFunding is opening its 2026 competition with a new structure designed to better serve startup founders across the state. A flagship event of TENWEST, IdeaFunding continues to provide early-stage companies with mentorship and pitch training and the opportunity to compete for cash prizes and awards. Applications are now open for businesses across Arizona to join the competition, including a chance to pitch to Jason Feifer, Editor-in-Chief of Entrepreneur Magazine, who will serve as one of the Main Stage Showcase judges.Continue reading→

LG NOVA-Supported Fund and Investment Vehicle Welcomes New Investors in NovaWave Fund I Generation to Accelerate AI-First Company Creation in American West and AppalachiaContinue reading→

Engineering faculty members are taking their inventions to market through entrepreneurial venturesContinue reading→

Acquisition adds next-generation CLAAS® AcuFORM™ Technology to Gore’s portfolio

Continue reading→

TUCSON, Ariz., Dec. 30, 2025 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems, LLC, maker of the world’s first total artificial heart approved by both the U.S. Food and Drug Administration (FDA) and Health Canada today announced that Patrick NJ Schnegelsberg, Chief Executive Officer of Picard Medical and SynCardia Systems, LLC, has been elected to the Board of Directors of the Arizona Bioindustry Association (AZBio), the state affiliate in Arizona of the Biotechnology Industry Organization (BIO), the preeminent national association for biotechnology companies His term serving on the board will extend through December 2028.Continue reading→

TUCSON, Ariz., Dec. 24, 2025 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that it has entered into a definitive agreement for a private placement financing of up to $50.0 million aggregate principal amount of senior secured notes due 2028 together with warrants to purchase common stock of the Company. WestPark Capital Inc. served as Sole Placement Agent.Continue reading→

Government, health care and academic leaders gather for annual State of the Phoenix Bioscience Core in downtown Phoenix

Continue reading→